Pacific Premier Bancorp (NASDAQ:PPBI – Free Report) had its price target reduced by DA Davidson from $32.00 to $27.00 in a research note released on Thursday, Benzinga reports. They currently have a buy rating on the financial services provider’s stock. DA Davidson also issued estimates for Pacific Premier Bancorp’s Q2 2024 earnings at $0.43 EPS […]
Pacific Premier Bancorp (NASDAQ:PPBI – Free Report) had its price target reduced by DA Davidson from $32.00 to $27.00 in a research note released on Thursday, Benzinga reports. They currently have a buy rating on the financial services provider’s stock. DA Davidson also issued estimates for Pacific Premier Bancorp’s Q2 2024 earnings at $0.43 EPS […]
Investment Analysts’ price target changes for Thursday, April 25th: Acrivon Therapeutics (NASDAQ:ACRV) had its target price boosted by Piper Sandler from $26.00 to $30.00. Piper Sandler currently has an overweight rating on the stock. Align Technology (NASDAQ:ALGN) had its target price raised by Robert W. Baird from $333.00 to $370.00. Robert W. Baird currently has […]
Pacific Premier Bancorp (NASDAQ:PPBI – Get Free Report) posted its quarterly earnings data on Wednesday. The financial services provider reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.01, Briefing.com reports. Pacific Premier Bancorp had a return on equity of 7.50% and a net margin of 24.75%. The business […]
Pacific Premier Bancorp (NASDAQ:PPBI – Get Free Report) released its quarterly earnings data on Wednesday. The financial services provider reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.01, Briefing.com reports. Pacific Premier Bancorp had a net margin of 24.75% and a return on equity of 7.50%. The firm had revenue […]